相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diet-Derived Gallated Catechins Prevent TGF-β-Mediated Epithelial-Mesenchymal Transition, Cell Migration and Vasculogenic Mimicry in Chemosensitive ES-2 Ovarian Cancer Cells
Audrey-Ann Sicard et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer
Amanda L. Tauber et al.
NUTRITION RESEARCH (2020)
(-)-Epigallocatechin-3-gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr/Abl-mediated p38-MAPK/JNK and JAK2/STAT3/AKT signalling pathways
Xiang Xiao et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
(-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway
Xiaoqin La et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study
Dina Sabry et al.
MOLECULAR BIOLOGY REPORTS (2019)
Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes
Gauri Deb et al.
MOLECULAR CARCINOGENESIS (2019)
Modulation of Myb-induced NF-kB-STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors
Miao Tian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model
Nithya Ramesh et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
Natalia Perez-Moral et al.
MOLECULES (2019)
Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells
Somaye Mirzaaghaei et al.
ACS OMEGA (2019)
Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy When Combined with Gemcitabine
Ran Wei et al.
NUTRIENTS (2019)
Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells
Kayla A. Lewis et al.
CANCERS (2019)
Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-beta 1/Smad signaling pathways
Tingting Li et al.
BIOENGINEERED (2019)
Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells
Veronika Borutinskaite et al.
LEUKEMIA & LYMPHOMA (2018)
Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma
Yasmin M. Shaalan et al.
NATURAL PRODUCT RESEARCH (2018)
Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RAR and HDAC1
Maliheh Moradzadeh et al.
PHYTOTHERAPY RESEARCH (2018)
Stealth and Fully-Laden Drug Carriers: Self-Assembled Nanogels Encapsulated with Epigallocatechin Gallate and siRNA for Drug-Resistant Breast Cancer Therapy
Jie Ding et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial
Cheol Min Shin et al.
CLINICAL NUTRITION (2018)
Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
Nadda Muhamad et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
Wanchun Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer
B. N. Prashanth Kumar et al.
MOLECULAR PHARMACEUTICS (2018)
In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-O-gallate (EGCG) with Proteins That Explain the Health Benefits of Green Tea
Koichi Saeki et al.
MOLECULES (2018)
Main trends of immune effects triggered by nanomedicines in preclinical studies
Blanka Halamoda-Kenzaoui et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer
Pan Jiang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells
Pan Jiang et al.
MOLECULAR CARCINOGENESIS (2018)
Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
Anchalee Rawangkan et al.
MOLECULES (2018)
Epigallocatechin Gallate Preferentially Inhibits O6-Methylguanine DNA-Methyltransferase Expression in Glioblastoma Cells Rather than in Nontumor Glial Cells
Chao-Ran Xie et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2018)
Molecular Targets of EpigallocatechinGallate (EGCG): A Special Focus on Signal Transduction and Cancer
Aide Negri et al.
NUTRIENTS (2018)
Controlled drug delivery vehicles for cancer treatment and their performance
Sudipta Senapati et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
(-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells
Le Ying et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling
Chien-Han Yuan et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials
Beatrix Peter et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2017)
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
Tae Won Kwak et al.
ONCOTARGETS AND THERAPY (2017)
The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms
Yue-Wern Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Down-regulation of histone deacetylase 4,-5 and-6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin
Yukiko Oya et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity
Vikrant Borse et al.
CELL DEATH & DISEASE (2017)
Epigallocatechin gallate inhibits the growth of MDA-MB-231 breast cancer cells via inactivation of the β-catenin signaling pathway
On-Yu Hong et al.
ONCOLOGY LETTERS (2017)
(-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway
Yue Chen et al.
NUTRIENTS (2017)
Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
Andreia Granja et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Combination curcumin and (-)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
G. Jin et al.
ONCOGENESIS (2017)
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy
Vanna Sanna et al.
SCIENTIFIC REPORTS (2017)
A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer
Hamed Samavat et al.
CANCER PREVENTION RESEARCH (2017)
A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer
Matteo Lazzeroni et al.
CANCER PREVENTION RESEARCH (2017)
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers
Jason R. Gee et al.
CANCER PREVENTION RESEARCH (2017)
EGCG sensitizes human nasopharyngeal carcinoma cells to TRAIL-mediated apoptosis by activation NF-κB
P. Li et al.
NEOPLASMA (2017)
Improving the Anticancer Efficacy of Laminin Receptor-Specific Therapeutic Ruthenium Nanoparticles (RuBB-Loaded EGCG-RuNPs) via ROS-Dependent Apoptosis in SMMC-7721 Cells
Yanhui Zhou et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial
Hamed Samavat et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy
Hanxi Zhao et al.
BRITISH JOURNAL OF RADIOLOGY (2016)
Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
Yoo Seob Shin et al.
PHYTOMEDICINE (2016)
Effect of Tea Polyphenol Compounds on Anticancer Drugs in Terms of Anti-Tumor Activity, Toxicology, and Pharmacokinetics
Jianhua Cao et al.
NUTRIENTS (2016)
NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
Pan Jiang et al.
ONCOTARGET (2016)
Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
Shusuke Toden et al.
ONCOTARGET (2016)
Activation of autophagic flux by epigallocatechin gallate mitigates TRAIL-induced tumor cell apoptosis via down-regulation of death receptors
Sung-Wook Kim et al.
ONCOTARGET (2016)
A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia
Ji Hoon Jung et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention
Nagi B. Kumar et al.
CANCER PREVENTION RESEARCH (2015)
Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus
Andrew K. Joe et al.
CANCER PREVENTION RESEARCH (2015)
Paclitaxel/Epigallocatechin gallate coloaded liposome: A synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells
Satiesh Kumar Ramadass et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma
Injie Omar Fawzy et al.
FEBS LETTERS (2015)
The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial
Allison M. Dostal et al.
FOOD AND CHEMICAL TOXICOLOGY (2015)
Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection - synthesis, characterization and in vitro evaluation
Sudeshna Mukherjee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells
Sreeja Narayanan et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
(-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells
Munawwar Ali Khan et al.
ONCOLOGY REPORTS (2015)
Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study
Seyedeh Sara Shafiei et al.
PLOS ONE (2015)
A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer
Hanxi Zhao et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Malin Wickstrom et al.
NATURE COMMUNICATIONS (2015)
Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis
Ruojing Wei et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model
Naghma Khan et al.
CARCINOGENESIS (2014)
Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities
Vanna Sanna et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Genipin-Structured Peptide-Polysaccharide Nanoparticles with Significantly Improved Resistance to Harsh Gastrointestinal Environments and Their Potential for Oral Delivery of Polyphenols
Bing Hu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2014)
Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo
Imtiaz A. Siddiqui et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Quercetin and EGCG Exhibit Chemopreventive Effects in Cholangiocarcinoma Cells via Suppression of JAK/STAT Signaling Pathway
Laddawan Senggunprai et al.
PHYTOTHERAPY RESEARCH (2014)
Increased STAT1 Signaling in Endocrine-Resistant Breast Cancer
Rui Huang et al.
PLOS ONE (2014)
A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer
Hanxi Zhao et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells
Cheng-Cheung Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1
Mayada Achour et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
Tait D. Shanafelt et al.
CANCER (2013)
TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in Human A549 lung cancer cells
Hyeonseok Ko et al.
CANCER LETTERS (2013)
Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway
Sang Hyuk Lee et al.
EUROPEAN JOURNAL OF CANCER (2013)
Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells
Rita Castillo Cohen de Pace et al.
JOURNAL OF LIPOSOME RESEARCH (2013)
Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals
Reem N. Abou El Naga et al.
LIFE SCIENCES (2013)
Tea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs
Amal Alotaibi et al.
NANOMEDICINE (2013)
A new world of Polycombs: unexpected partnerships and emerging functions
Yuri B. Schwartz et al.
NATURE REVIEWS GENETICS (2013)
Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling
Heiying Jin et al.
ONCOTARGETS AND THERAPY (2013)
Gold nanoparticles as novel agents for cancer therapy
S. Jain et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Effect of 2-Month Controlled Green Tea Intervention on Lipoprotein Cholesterol, Glucose, and Hormone Levels in Healthy Postmenopausal Women
Anna H. Wu et al.
CANCER PREVENTION RESEARCH (2012)
Design of polymeric nanoparticles for biomedical delivery applications
Mahmoud Elsabahy et al.
CHEMICAL SOCIETY REVIEWS (2012)
Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases
Vijay S. Thakur et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
EGCG Inhibits Transforming Growth Factor-β-Mediated Epithelial-to-Mesenchymal Transition via the Inhibition of Smad2 and Erk1/2 Signaling Pathways in Nonsmall Cell Lung Cancer Cells
Liang-Chih Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
(-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells
Kengo Ogawa et al.
ONCOLOGY LETTERS (2012)
The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles
Dar-Shih Hsieh et al.
BIOMATERIALS (2011)
(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells
Vijayalakshmi Nandakumar et al.
CARCINOGENESIS (2011)
Targeted Biocompatible Nanoparticles for tie Delivery of (-)-Epigallocatechin 3-Gallate to Prostate Cancer Cells
Vanna Sanna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention
Sandra Rocha et al.
NANOMEDICINE (2011)
SU5416 and EGCG Work Synergistically and Inhibit Angiogenic and Survival Factors and Induce Cell Cycle Arrest to Promote Apoptosis in Human Malignant Neuroblastoma SH-SY5Y and SK-N-BE2 Cells
Nishant Mohan et al.
NEUROCHEMICAL RESEARCH (2011)
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
X. Rao et al.
ONCOGENE (2011)
The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival
Sivaprakasam Balasubramanian et al.
CARCINOGENESIS (2010)
(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells
Masahito Shimizu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Indoleamine 2,3-Dioxygenase, an Immunomodulatory Protein, Is Suppressed by (-)-Epigallocatechin-3-gallate via Blocking of γ-Interferon-Induced JAK-PKC-δ-STAT1 Signaling in Human Oral Cancer Cells
Chieh-Wen Cheng et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
IKKα controls canonical TGFβ-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in Panc1 cells
Martina Brandl et al.
JOURNAL OF CELL SCIENCE (2010)
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
Hugues de The et al.
NATURE REVIEWS CANCER (2010)
TGFβ signalling: a complex web in cancer progression
Hiroaki Ikushima et al.
NATURE REVIEWS CANCER (2010)
Layer-by-Layer-Coated Gelatin Nanoparticles as a Vehicle for Delivery of Natural Polyphenols
Tatsiana G. Shutava et al.
ACS NANO (2009)
Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitro
Jerry McLarty et al.
CANCER PREVENTION RESEARCH (2009)
Introducing Nanochemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-Gallate
Imtiaz A. Siddiqui et al.
CANCER RESEARCH (2009)
(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis
Yohei Shirakami et al.
CANCER SCIENCE (2009)
Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death
Aruna Basu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Chung S. Yang et al.
NATURE REVIEWS CANCER (2009)
A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
M. J. Scandlyn et al.
BRITISH JOURNAL OF CANCER (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma
M. D. Siegelin et al.
NEUROSCIENCE LETTERS (2008)
Multifunctional nanoparticles - properties and prospects for their use in human medicine
Nuria Sanvicens et al.
TRENDS IN BIOTECHNOLOGY (2008)
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis
I. A. Siddiqui et al.
ONCOGENE (2008)
Nanoparticles and their biological and environmental applications
Wen-Tso Liu
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2006)
Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas
Jia-You Fang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
Engineered nanoparticles as precise drug delivery systems
TC Yih et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study
S Bettuzzi et al.
CANCER RESEARCH (2006)
VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance
YK Lee et al.
LEUKEMIA (2005)
Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations
JY Fang et al.
JOURNAL OF DRUG TARGETING (2005)
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia
YK Lee et al.
BLOOD (2004)
How cells read TGF-β signals
J Massagué
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
分享论文
